<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38514653</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>21</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Parechovirus infection in human brain organoids: host innate inflammatory response and not neuro-infectivity correlates to neurologic disease.</ArticleTitle><Pagination><StartPage>2532</StartPage><MedlinePgn>2532</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2532</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-46634-9</ELocationID><Abstract><AbstractText>Picornaviruses are a leading cause of central nervous system (CNS) infections. While genotypes such as parechovirus A3 (PeV-A3) and echovirus 11 (E11) can elicit severe neurological disease, the highly prevalent PeV-A1 is not associated with CNS disease. Here, we expand our current understanding of these differences in PeV-A CNS disease using human brain organoids and clinical isolates of the two PeV-A genotypes. Our data indicate that PeV-A1 and A3 specific differences in neurological disease are not due to infectivity of CNS cells as both viruses productively infect brain organoids with a similar cell tropism. Proteomic analysis shows that PeV-A infection significantly alters the host cell metabolism. The inflammatory response following PeV-A3 (and E11 infection) is significantly more potent than that upon PeV-A1 infection. Collectively, our findings align with clinical observations and suggest a role for neuroinflammation, rather than viral replication, in PeV-A3 (and E11) infection.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Capendale</LastName><ForeName>Pamela E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>OrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OrganoVIR Labs, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>García-Rodríguez</LastName><ForeName>Inés</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-5795-4495</Identifier><AffiliationInfo><Affiliation>OrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OrganoVIR Labs, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambikan</LastName><ForeName>Anoop T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>The Systems Virology Lab, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulder</LastName><ForeName>Lance A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>OrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OrganoVIR Labs, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Depla</LastName><ForeName>Josse A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>OrganoVIR Labs, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UniQure Biopharma B.V., Department of Research &amp; Development, Paasheuvelweg 25A, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeze</LastName><ForeName>Eline</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>OrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OrganoVIR Labs, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koen</LastName><ForeName>Gerrit</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>OrganoVIR Labs, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calitz</LastName><ForeName>Carlemi</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9751-1162</Identifier><AffiliationInfo><Affiliation>OrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OrganoVIR Labs, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sood</LastName><ForeName>Vikas</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>The Systems Virology Lab, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieira de Sá</LastName><ForeName>Renata</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>OrganoVIR Labs, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Systems Virology Lab, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neogi</LastName><ForeName>Ujjwal</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-0844-3338</Identifier><AffiliationInfo><Affiliation>The Systems Virology Lab, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pajkrt</LastName><ForeName>Dasja</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-5232-8206</Identifier><AffiliationInfo><Affiliation>OrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OrganoVIR Labs, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sridhar</LastName><ForeName>Adithya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2986-4884</Identifier><AffiliationInfo><Affiliation>OrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OrganoVIR Labs, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emma Center for Personalized Medicine, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wolthers</LastName><ForeName>Katja C</ForeName><Initials>KC</Initials><Identifier Source="ORCID">0000-0003-1617-7049</Identifier><AffiliationInfo><Affiliation>OrganoVIR Labs, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands. k.c.wolthers@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>812673</GrantID><Agency>EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)</Agency><Country /></Grant><Grant><GrantID>812673</GrantID><Agency>EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030061" MajorTopicYN="Y">Parechovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002493" MajorTopicYN="Y">Central Nervous System Diseases</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>J.A.D. and R.S. are employees and/or shareholders of UniQure Biopharma B.V. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38514653</ArticleId><ArticleId IdType="pmc">PMC10958052</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-46634-9</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-46634-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wolthers KC, et al. Human parechoviruses as an important viral cause of sepsislike illness and meningitis in young children. Clin. Infect. Dis. 2008;47:358–363. doi: 10.1086/589752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/589752</ArticleId><ArticleId IdType="pubmed">18558876</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sanden S, et al. Prevalence of human parechovirus in the Netherlands in 2000 to 2007. J. Clin. Microbiol. 2008;46:2884–2889. doi: 10.1128/JCM.00168-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00168-08</ArticleId><ArticleId IdType="pmc">PMC2546772</ArticleId><ArticleId IdType="pubmed">18614653</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K, Hirokawa C, Tazawa T. Seropositivity and epidemiology of human parechovirus types 1, 3, and 6 in Japan. Epidemiol. Infect. 2016;144:3451–3460. doi: 10.1017/S0950268816001795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268816001795</ArticleId><ArticleId IdType="pmc">PMC9150201</ArticleId><ArticleId IdType="pubmed">27571735</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedi GR, et al. Enterovirus and human parechovirus surveillance—United States, 2009–2013. MMWR Morb. Mortal. Wkly. Rep. 2015;64:940–943. doi: 10.15585/mmwr.mm6434a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6434a3</ArticleId><ArticleId IdType="pubmed">26334674</ArticleId></ArticleIdList></Reference><Reference><Citation>Coller BA, et al. Echovirus 22 is an atypical enterovirus. J. Virol. 1990;64:2692–2701. doi: 10.1128/jvi.64.6.2692-2701.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.64.6.2692-2701.1990</ArticleId><ArticleId IdType="pmc">PMC249448</ArticleId><ArticleId IdType="pubmed">2159539</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfon N, Spector SA. Fatal echovirus type 11 infections. Am. J. Dis. Child. 1981;135:1017–1020.</Citation><ArticleIdList><ArticleId IdType="pubmed">7294006</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullahi AM, Sarmast ST, Singh R. Molecular biology and epidemiology of neurotropic viruses. Cureus. 2020;12:e9674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7485989</ArticleId><ArticleId IdType="pubmed">32923269</ArticleId></ArticleIdList></Reference><Reference><Citation>Tebruegge M, Curtis N. Enterovirus infections in neonates. Semin. Fetal Neonatal Med. 2009;14:222–227. doi: 10.1016/j.siny.2009.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.siny.2009.02.002</ArticleId><ArticleId IdType="pubmed">19303380</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer L, Betrian MRE, Pajkrt D, Wolthers KC. World-wide prevalence and genotype distribution of parechovirus A. Virol. Retrovirol. J. 2019;2:1–7.</Citation></Reference><Reference><Citation>Romero JR, Selvarangan R. The human parechoviruses: an overview. Adv. Pediatr. 2011;58:65–85. doi: 10.1016/j.yapd.2011.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yapd.2011.03.008</ArticleId><ArticleId IdType="pubmed">21736976</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop KSM, et al. Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin. Infect. Dis. 2006;42:204–210. doi: 10.1086/498905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/498905</ArticleId><ArticleId IdType="pubmed">16355330</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. HAN00469. Recent reports of human parechovirus (PeV) in the United States—2022.https://emergency.cdc.gov/han/2022/han00469.asp (2022).</Citation></Reference><Reference><Citation>Ito M, Yamashita T, Tsuzuki H, Takeda N, Sakae K. Isolation and identification of a novel human parechovirus. J. Gen. Virol. 2004;85:391–398. doi: 10.1099/vir.0.19456-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19456-0</ArticleId><ArticleId IdType="pubmed">14769896</ArticleId></ArticleIdList></Reference><Reference><Citation>Verboon-Maciolek MA, et al. Human parechovirus causes encephalitis with white matter injury in neonates. Ann. Neurol. 2008;64:266–273. doi: 10.1002/ana.21445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21445</ArticleId><ArticleId IdType="pubmed">18825694</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Wolthers KC, Simmonds P. Parechoviruses in children: understanding a new infection. Curr. Opin. Infect. Dis. 2010;23:224–230. doi: 10.1097/QCO.0b013e32833890ca.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0b013e32833890ca</ArticleId><ArticleId IdType="pubmed">20414971</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hinsbergh TMT, Elbers RG, Hans Ket JCF, van Furth AM, Obihara CC. Neurological and neurodevelopmental outcomes after human parechovirus CNS infection in neonates and young children: a systematic review and meta-analysis. Lancet Child Adolesc. Health. 2020;4:592–605. doi: 10.1016/S2352-4642(20)30181-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30181-4</ArticleId><ArticleId IdType="pubmed">32710840</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton PN, et al. Parechovirus encephalitis and neurodevelopmental outcomes. Pediatrics. 2016;137:e20152848. doi: 10.1542/peds.2015-2848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2015-2848</ArticleId><ArticleId IdType="pubmed">26791970</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerhuis BM, et al. Specific cell tropism and neutralization of human parechovirus types 1 and 3: implications for pathogenesis and therapy development. J. Gen. Virol. 2012;93:2363–2370. doi: 10.1099/vir.0.043323-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.043323-0</ArticleId><ArticleId IdType="pubmed">22837420</ArticleId></ArticleIdList></Reference><Reference><Citation>Merilahti P, Karelehto E, Susi P. Role of heparan sulfate in cellular infection of integrin-binding coxsackievirus A9 and human parechovirus 1 isolates. PLoS ONE. 2016;11:e0147168. doi: 10.1371/journal.pone.0147168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0147168</ArticleId><ArticleId IdType="pmc">PMC4718452</ArticleId><ArticleId IdType="pubmed">26785353</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou K, Triantafilou M, Takada Y, Fernandez N. Human parechovirus 1 utilizes integrins αvβ3 and αvβ1 as receptors. J. Virol. 2000;74:5856–5862. doi: 10.1128/JVI.74.13.5856-5862.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.13.5856-5862.2000</ArticleId><ArticleId IdType="pmc">PMC112080</ArticleId><ArticleId IdType="pubmed">10846065</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K, et al. Myeloid-associated differentiation marker is an essential host factor for human parechovirus PeV-A3 entry. Nat. Commun. 2023;14:1817. doi: 10.1038/s41467-023-37399-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-37399-8</ArticleId><ArticleId IdType="pmc">PMC10066301</ArticleId><ArticleId IdType="pubmed">37002207</ArticleId></ArticleIdList></Reference><Reference><Citation>Karelehto E, et al. Polarized entry of human parechoviruses in the airway epithelium. Front. Cell Infect. Microbiol. 2018;8:294. doi: 10.3389/fcimb.2018.00294.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2018.00294</ArticleId><ArticleId IdType="pmc">PMC6119779</ArticleId><ArticleId IdType="pubmed">30211126</ArticleId></ArticleIdList></Reference><Reference><Citation>Jan MW, Su HL, Chang TH, Tsai KJ. Characterization of pathogenesis and inflammatory responses to experimental parechovirus encephalitis. Front. Immunol. 2021;12:753683. doi: 10.3389/fimmu.2021.753683.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.753683</ArticleId><ArticleId IdType="pmc">PMC8654935</ArticleId><ArticleId IdType="pubmed">34899705</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridhar, A. et al. A perspective on organoids for virology research. Viruses12, 1341 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7700289</ArticleId><ArticleId IdType="pubmed">33238561</ArticleId></ArticleIdList></Reference><Reference><Citation>Pașca SP, et al. A nomenclature consensus for nervous system organoids and assembloids. Nature. 2022;609:907–910. doi: 10.1038/s41586-022-05219-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05219-6</ArticleId><ArticleId IdType="pmc">PMC10571504</ArticleId><ArticleId IdType="pubmed">36171373</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancaster MA, et al. Cerebral organoids model human brain development and microcephaly. Nature. 2013;501:373–379. doi: 10.1038/nature12517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12517</ArticleId><ArticleId IdType="pmc">PMC3817409</ArticleId><ArticleId IdType="pubmed">23995685</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasca SP. The rise of three-dimensional human brain cultures. Nature. 2018;553:437–445. doi: 10.1038/nature25032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature25032</ArticleId><ArticleId IdType="pubmed">29364288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelava I, Lancaster MA. Dishing out mini-brains: current progress and future prospects in brain organoid research. Dev. Biol. 2016;420:199–209. doi: 10.1016/j.ydbio.2016.06.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2016.06.037</ArticleId><ArticleId IdType="pmc">PMC5161139</ArticleId><ArticleId IdType="pubmed">27402594</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiaradia I, Lancaster MA. Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo. Nat. Neurosci. 2020;23:1496–1508. doi: 10.1038/s41593-020-00730-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00730-3</ArticleId><ArticleId IdType="pubmed">33139941</ArticleId></ArticleIdList></Reference><Reference><Citation>Depla, J. A. et al. Human brain organoids as models for central nervous system viral infection. Viruses14, 634 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8948955</ArticleId><ArticleId IdType="pubmed">35337041</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang J, et al. Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3. Cell Stem Cell. 2016;19:258–265. doi: 10.1016/j.stem.2016.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2016.04.014</ArticleId><ArticleId IdType="pmc">PMC5116380</ArticleId><ArticleId IdType="pubmed">27162029</ArticleId></ArticleIdList></Reference><Reference><Citation>Cugola FR, et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature. 2016;534:267–271. doi: 10.1038/nature18296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18296</ArticleId><ArticleId IdType="pmc">PMC4902174</ArticleId><ArticleId IdType="pubmed">27279226</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Aiuto, L. et al. Modeling herpes simplex virus 1 infections in human central nervous system neuronal cells using two- and three-dimensional cultures derived from induced pluripotent stem cells. J. Virol.93, e00111–19 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6475775</ArticleId><ArticleId IdType="pubmed">30787148</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, R. M. et al. Human cytomegalovirus compromises development of cerebral organoids. J. Virol.93, e00957-19 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6694831</ArticleId><ArticleId IdType="pubmed">31217239</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullen CK, et al. Infectability of human brainsphere neurons suggests neurotropism of SARS-CoV-2. ALTEX. 2020;37:665–671.</Citation><ArticleIdList><ArticleId IdType="pubmed">32591839</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob F, et al. Human pluripotent stem cell-derived neural cells and brain organoids reveal SARS-CoV-2 neurotropism predominates in choroid plexus epithelium. Cell Stem Cell. 2020;27:937–950.e939. doi: 10.1016/j.stem.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7505550</ArticleId><ArticleId IdType="pubmed">33010822</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahey GM, Lindsey NP, Staples JE, Hills SL. La Crosse virus disease in the United States, 2003-2019. Am. J. Trop. Med. Hyg. 2021;105:807–812. doi: 10.4269/ajtmh.21-0294.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.21-0294</ArticleId><ArticleId IdType="pmc">PMC8592351</ArticleId><ArticleId IdType="pubmed">34280142</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridhar A, et al. Enterovirus D68 infection in human primary airway and brain organoids: no additional role for heparan sulfate binding for neurotropism. Microbiol. Spectr. 2022;10:e0169422. doi: 10.1128/spectrum.01694-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01694-22</ArticleId><ArticleId IdType="pmc">PMC9603061</ArticleId><ArticleId IdType="pubmed">36154279</ArticleId></ArticleIdList></Reference><Reference><Citation>Wildenbeest JG, et al. Pleconaril revisited: clinical course of chronic enteroviral meningoencephalitis after treatment correlates with in vitro susceptibility. Antivir. Ther. 2012;17:459–466. doi: 10.3851/IMP1936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP1936</ArticleId><ArticleId IdType="pubmed">22293148</ArticleId></ArticleIdList></Reference><Reference><Citation>Renner M, et al. Self-organized developmental patterning and differentiation in cerebral organoids. EMBO J. 2017;36:1316–1329. doi: 10.15252/embj.201694700.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201694700</ArticleId><ArticleId IdType="pmc">PMC5430225</ArticleId><ArticleId IdType="pubmed">28283582</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science. 2014;345:1247125. doi: 10.1126/science.1247125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1247125</ArticleId><ArticleId IdType="pubmed">25035496</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian X, Nguyen HN, Jacob F, Song H, Ming GL. Using brain organoids to understand Zika virus-induced microcephaly. Development. 2017;144:952–957. doi: 10.1242/dev.140707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.140707</ArticleId><ArticleId IdType="pmc">PMC5358105</ArticleId><ArticleId IdType="pubmed">28292840</ArticleId></ArticleIdList></Reference><Reference><Citation>Krenn V, et al. Organoid modeling of Zika and herpes simplex virus 1 infections reveals virus-specific responses leading to microcephaly. Cell Stem Cell. 2021;28:1362–1379.e1367. doi: 10.1016/j.stem.2021.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.03.004</ArticleId><ArticleId IdType="pmc">PMC7611471</ArticleId><ArticleId IdType="pubmed">33838105</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasidharan A, Hassan WM, Harrison CJ, Hassan F, Selvarangan R. Host immune response to enterovirus and parechovirus systemic infections in children. Open Forum Infect. Dis. 2020;7:ofaa261. doi: 10.1093/ofid/ofaa261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa261</ArticleId><ArticleId IdType="pmc">PMC7443103</ArticleId><ArticleId IdType="pubmed">32855983</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalska A, Blaszczyk K, Wesoly J, Bluyssen HAR. A positive feedback amplifier circuit that regulates interferon (IFN)-stimulated gene expression and controls type I and type II IFN responses. Front. Immunol. 2018;9:1135. doi: 10.3389/fimmu.2018.01135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01135</ArticleId><ArticleId IdType="pmc">PMC5985295</ArticleId><ArticleId IdType="pubmed">29892288</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, et al. Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells. Cell Death Discov. 2021;7:114. doi: 10.1038/s41420-021-00487-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00487-z</ArticleId><ArticleId IdType="pmc">PMC8129603</ArticleId><ArticleId IdType="pubmed">34006825</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang R, et al. Expression and mechanisms of interferon-stimulated genes in viral infection of the central nervous system (CNS) and neurological diseases. Front. Immunol. 2022;13:1008072. doi: 10.3389/fimmu.2022.1008072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1008072</ArticleId><ArticleId IdType="pmc">PMC9618809</ArticleId><ArticleId IdType="pubmed">36325336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezeonwumelu, I. J., Garcia-Vidal, E. &amp; Ballana, E. JAK-STAT pathway: a novel target to tackle viral infections. Viruses13, 2379 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8704679</ArticleId><ArticleId IdType="pubmed">34960648</ArticleId></ArticleIdList></Reference><Reference><Citation>Good C, Wells AI, Coyne CB. Type III interferon signaling restricts enterovirus 71 infection of goblet cells. Sci. Adv. 2019;6:eaau4255. doi: 10.1126/sciadv.aau4255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aau4255</ArticleId><ArticleId IdType="pmc">PMC6402847</ArticleId><ArticleId IdType="pubmed">30854425</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascovici D, Handler DC, Wu JX, Haynes PA. Multiple testing corrections in quantitative proteomics: a useful but blunt tool. Proteomics. 2016;16:2448–2453. doi: 10.1002/pmic.201600044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201600044</ArticleId><ArticleId IdType="pubmed">27461997</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. 2013;13:379–393. doi: 10.1016/j.chom.2013.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2013.03.010</ArticleId><ArticleId IdType="pmc">PMC3647473</ArticleId><ArticleId IdType="pubmed">23601101</ArticleId></ArticleIdList></Reference><Reference><Citation>García-Rodríguez I, et al. Parechovirus A infection of the intestinal epithelium: differences between genotypes A1 and A3. Front. Cell Infect. Microbiol. 2021;11:740662. doi: 10.3389/fcimb.2021.740662.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.740662</ArticleId><ArticleId IdType="pmc">PMC8591172</ArticleId><ArticleId IdType="pubmed">34790587</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa JP, Ashley D, King D, Hull B. An outbreak of acute flaccid paralysis in Jamaica associated with echovirus type 22. J. Med. Virol. 1989;29:315–319. doi: 10.1002/jmv.1890290418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1890290418</ArticleId><ArticleId IdType="pubmed">2621458</ArticleId></ArticleIdList></Reference><Reference><Citation>Chonmaitree T, Baron S. Bacteria and viruses induce production of interferon in the cerebrospinal fluid of children with acute meningitis: a study of 57 cases and review. Rev. Infect. Dis. 1991;13:1061–1065. doi: 10.1093/clinids/13.6.1061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/13.6.1061</ArticleId><ArticleId IdType="pubmed">1723215</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells AI, Coyne CB. An in vivo model of echovirus-induced meningitis defines the differential roles of type I and type III interferon signaling in central nervous system infection. J. Virol. 2022;96:e0033022. doi: 10.1128/jvi.00330-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00330-22</ArticleId><ArticleId IdType="pmc">PMC9278148</ArticleId><ArticleId IdType="pubmed">35699446</ArticleId></ArticleIdList></Reference><Reference><Citation>Katze MG, Fornek JL, Palermo RE, Walters KA, Korth MJ. Innate immune modulation by RNA viruses: emerging insights from functional genomics. Nat. Rev. Immunol. 2008;8:644–654. doi: 10.1038/nri2377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2377</ArticleId><ArticleId IdType="pmc">PMC7097543</ArticleId><ArticleId IdType="pubmed">18654572</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain NK, et al. Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: a review. Front. Pharm. 2023;14:1135145. doi: 10.3389/fphar.2023.1135145.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2023.1135145</ArticleId><ArticleId IdType="pmc">PMC10067607</ArticleId><ArticleId IdType="pubmed">37021053</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy S. Why are RNA virus mutation rates so damn high? PLoS Biol. 2018;16:e3000003. doi: 10.1371/journal.pbio.3000003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000003</ArticleId><ArticleId IdType="pmc">PMC6107253</ArticleId><ArticleId IdType="pubmed">30102691</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridhar, A., Karelehto, E., Brouwer, L., Pajkrt, D. &amp; Wolthers, K. C. Parechovirus A pathogenesis and the enigma of genotype A-3. Viruses11, 1062 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6893760</ArticleId><ArticleId IdType="pubmed">31739613</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews MG, Kriegstein AR. Challenges of organoid research. Annu Rev. Neurosci. 2022;45:23–39. doi: 10.1146/annurev-neuro-111020-090812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-111020-090812</ArticleId><ArticleId IdType="pmc">PMC10559943</ArticleId><ArticleId IdType="pubmed">34985918</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasca AM, et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat. Methods. 2015;12:671–678. doi: 10.1038/nmeth.3415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3415</ArticleId><ArticleId IdType="pmc">PMC4489980</ArticleId><ArticleId IdType="pubmed">26005811</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon SJ, et al. Reliability of human cortical organoid generation. Nat. Methods. 2019;16:75–78. doi: 10.1038/s41592-018-0255-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-018-0255-0</ArticleId><ArticleId IdType="pmc">PMC6677388</ArticleId><ArticleId IdType="pubmed">30573846</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelemans, T. &amp; Kikkert, M. Viral innate immune evasion and the pathogenesis of emerging RNA virus infections. Viruses11, 961 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6832425</ArticleId><ArticleId IdType="pubmed">31635238</ArticleId></ArticleIdList></Reference><Reference><Citation>Devasthanam AS. Mechanisms underlying the inhibition of interferon signaling by viruses. Virulence. 2014;5:270–277. doi: 10.4161/viru.27902.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.27902</ArticleId><ArticleId IdType="pmc">PMC3956502</ArticleId><ArticleId IdType="pubmed">24504013</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson TM, et al. An outbreak of severe infections among Australian infants caused by a novel recombinant strain of human parechovirus type 3. Sci. Rep. 2017;7:44423. doi: 10.1038/srep44423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44423</ArticleId><ArticleId IdType="pmc">PMC5349594</ArticleId><ArticleId IdType="pubmed">28290509</ArticleId></ArticleIdList></Reference><Reference><Citation>Lelie PN, Reesink HW, Lucas CJ. Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccine. J. Med. Virol. 1987;23:297–301. doi: 10.1002/jmv.1890230313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1890230313</ArticleId><ArticleId IdType="pmc">PMC7166500</ArticleId><ArticleId IdType="pubmed">2828525</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen CL, Jensen JL, Ørntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;1:5245–5250. doi: 10.1158/0008-5472.CAN-04-0496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-04-0496</ArticleId><ArticleId IdType="pubmed">15289330</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints12. Am. J. Epidemiol. 1938;27:493–497. doi: 10.1093/oxfordjournals.aje.a118408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a118408</ArticleId></ArticleIdList></Reference><Reference><Citation>Akusjärvi SS, et al. Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: a cross-talk between glycolysis and HIF signaling. iScience. 2022;25:103607. doi: 10.1016/j.isci.2021.103607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103607</ArticleId><ArticleId IdType="pmc">PMC8718889</ArticleId><ArticleId IdType="pubmed">35005552</ArticleId></ArticleIdList></Reference><Reference><Citation>Willforss J, Chawade A, Levander F. NormalyzerDE: online tool for improved normalization of omics expression data and high-sensitivity differential expression analysis. J. Proteome Res. 2019;18:732–740. doi: 10.1021/acs.jproteome.8b00523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.8b00523</ArticleId><ArticleId IdType="pubmed">30277078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie T., Tibshirani R., Narasimhan B. &amp; Chu G. Impute: impute: imputation for microarray data. R package version 1.76.0. https://bioconductor.org/packages/impute (2023).</Citation></Reference><Reference><Citation>Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. doi: 10.1093/nar/gkv007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A, et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417–425. doi: 10.1016/j.cels.2015.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2015.12.004</ArticleId><ArticleId IdType="pmc">PMC4707969</ArticleId><ArticleId IdType="pubmed">26771021</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EY, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinforma. 2013;14:128. doi: 10.1186/1471-2105-14-128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-128</ArticleId><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Varemo L, Nielsen J, Nookaew I. Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods. Nucleic Acids Res. 2013;41:4378–4391. doi: 10.1093/nar/gkt111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt111</ArticleId><ArticleId IdType="pmc">PMC3632109</ArticleId><ArticleId IdType="pubmed">23444143</ArticleId></ArticleIdList></Reference><Reference><Citation>Croghan, C. W. &amp; Egeghy, P. P. Methods of Dealing with Values Below the Limit of Detection using SAS (Southeastern SAS User Group, accessed 22–24 September 2003); https://analytics.ncsu.edu/sesug/2003/SD08-Croghan.pdf.</Citation></Reference><Reference><Citation>Heberle H, Meirelles GV, da Silva FR, Telles GP, Minghim R. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinforma. 2015;16:169. doi: 10.1186/s12859-015-0611-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-015-0611-3</ArticleId><ArticleId IdType="pmc">PMC4455604</ArticleId><ArticleId IdType="pubmed">25994840</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32:2847–2849. doi: 10.1093/bioinformatics/btw313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw313</ArticleId><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>